Queen Mary University of London
DEBRA and Queen Mary partner to advance epidermolysis bullosa drug development
Around 500,000 people worldwide are affected by the group of rare genetic skin conditions
Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery
Approximately 500,000 people worldwide are affected by the rare genetic skin disorders
Researchers discover previously unidentified genes linked to rare diseases
Up to 80% of rare disease patients remain undiagnosed after genomic sequencing
LEO and DEBRA Research partner to advance epidermolysis bullosa treatments
There is currently no cure for the group of rare inherited skin disorders
UK scientists reveal promising new treatment strategy for acute myeloid leukaemia
The aggressive form of blood cancer is responsible for more than 3,000 new cases in the UK every year
UK national study supports whole genome sequencing in standard cancer care
The trial combined data from the UK’s 100,000 Genomes Project and NHS records
ICR study reveals how cancers can evolve without relying on DNA mutations
The researchers found that epigenetic changes play a key role in how cancers adapt and evolve